Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir-containing regimens in chronic HCV infection
NCT01826981Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Apr 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of sofosbuvir in hepatitis C (HCV), sponsored by Gilead Sciences. Started Apr 2013; status: completed.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01826981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01826981.